Prosl FR - Search Results

1

Dialock: a new vascular access device for extracorporeal renal replacement therapy. Preliminary clinical results.

Canaud B, My H, Morena M, Lamy-Lacavalerie B, Leray-Moragues H, Bosc JY, Flavier JL, Chomel PY, Polaschegg HD, Prosl FR, Megerman J. Canaud B, et al. Among authors: prosl fr. Nephrol Dial Transplant. 1999 Mar;14(3):692-8. doi: 10.1093/ndt/14.3.692. Nephrol Dial Transplant. 1999. PMID: 10193821

2

New access device for hemodialysis.

Levin NW, Yang PM, Hatch DA, Dubrow AJ, Caraiani NS, Ing TS, Gandhi VC, Alto A, Davila SM, Prosl FR, Polaschegg HD, Megerman J. Levin NW, et al. Among authors: prosl fr. ASAIO J. 1998 Sep-Oct;44(5):M529-31. doi: 10.1097/00002480-199809000-00042. ASAIO J. 1998. PMID: 9804487 Clinical Trial.

3

Initial results of a new access device for hemodialysis technical note.

Levin NW, Yang PM, Hatch DA, Dubrow AJ, Caraiani NS, Ing TS, Gandhi VC, Alto A, Davila SM, Prosl FR, Polaschegg HD, Megerman J. Levin NW, et al. Among authors: prosl fr. Kidney Int. 1998 Nov;54(5):1739-45. doi: 10.1046/j.1523-1755.1998.00128.x. Kidney Int. 1998. PMID: 9844153 Free article.

4

Development of a new approach to vascular access.

Megerman J, Levin NW, Ing TS, Dubrow AJ, Prosl FR. Megerman J, et al. Among authors: prosl fr. Artif Organs. 1999 Jan;23(1):10-4. doi: 10.1046/j.1525-1594.1999.06286.x. Artif Organs. 1999. PMID: 9950173

5

Adjunctive antibiotic/anticoagulant lock therapy in the treatment of bacteremia associated with the use of a subcutaneously implanted hemodialysis access device.

Boorgu R, Dubrow AJ, Levin NW, My H, Canaud BJ, Lentino JR, Wentworth DW, Hatch DA, Megerman J, Prosl FR, Gandhi VC, Ing TS. Boorgu R, et al. Among authors: prosl fr. ASAIO J. 2000 Nov-Dec;46(6):767-70. doi: 10.1097/00002480-200011000-00021. ASAIO J. 2000. PMID: 11110278

6

New hemodialysis access system.

Prosl F, Polaschegg HD. Prosl F, et al. Blood Purif. 2013;35(1-3):72-6. doi: 10.1159/000345180. Epub 2013 Jan 22. Blood Purif. 2013. PMID: 23343549

7

Totally implantable subcutaneous devices for hemodialysis access.

Moran JE, Prosl F. Moran JE, et al. Contrib Nephrol. 2004;142:178-92. doi: 10.1159/000074861. Contrib Nephrol. 2004. PMID: 14719393 Review.

8

A two-phase fluid powered insulin infusion pump with basal-bolus capability which compensates for pressure and temperature variability.

Dorman FD, Rohde TD, Arlt GJ, Wigness BD, Prosl FR, Blackshear PJ, Buchwald H. Dorman FD, et al. Among authors: prosl fr. Trans Am Soc Artif Intern Organs. 1981;27:236-40. Trans Am Soc Artif Intern Organs. 1981. PMID: 7331080 No abstract available.

9

The implantable infusion pump: a new concept in drug delivery.

Blackshear PJ, Rohde TD, Prosl F, Buchwald H. Blackshear PJ, et al. Med Prog Technol. 1979 Nov 30;6(4):149-61. Med Prog Technol. 1979. PMID: 160505

10

A totally implantable drug infusion defice: laboratory and clinical experience using a model with single flow rate and new design for modulated insulin infusion.

Buchwald H, Rohde TD, Dorman FD, Skakoon JG, Wigness BD, Prosl FR, Tucker EM, Rublein TG, Blackshear PJ, Varco RL. Buchwald H, et al. Among authors: prosl fr. Diabetes Care. 1980 Mar-Apr;3(2):351-8. doi: 10.2337/diacare.3.2.351. Diabetes Care. 1980. PMID: 6993152

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters